AI In Cosmetic Formulation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The aI in cosmetic formulation market size is expected to increase from USD 0.36 billion in 2025 to USD 0.49 billion in 2026 and reach USD 1.41 billion by 2031, growing at a CAGR of 23.44% over 2026-2031. This report is Segmented by Component (Software, Services, Hardware and Lab Automation Tools), Deployment Mode (Cloud, On-Premises, Hybrid and Private Cloud), Application (Product Development, Ingredient Analysis and Discovery, and More), End User (Cosmetic Manufacturers, Personal Care Brands, and More), and Geography (North America, and More). Market Forecasts are Provided in Terms of Value (USD).

Global AI In Cosmetic Formulation Market Trends and Insights

Demand for Hyper-Personalized Beauty

Consumer demand has moved beyond broad skin categories, and the AI in cosmetic formulation market is gaining because brands increasingly need formulation systems that can respond to individual biology, lifestyle inputs, and environmental conditions. This shift changes personalization from a marketing message into an operating model, since companies now need tools that can translate consumer data into viable formulas without expanding development time or cost. In this setting, AI narrows a vast formulation search space into a smaller set of workable options, which makes personalized product design more practical for brands that want speed as well as specificity. It also raises the value of platforms that sit close to ingredient libraries, testing data, and production planning, because those systems become harder to replace once they are embedded in daily formulation work.

The result is that the AI in cosmetic formulation market is not only responding to demand for customized products, it is also being shaped by the need to industrialize customization in a repeatable way. Scientific literature on AI-led personalization in cosmetics supports this direction, especially where predictive modeling is used to improve fit between consumer profiles and formulation outcomes.

Faster Formulation Cycles

Speed remains one of the clearest reasons brands are investing in the AI in cosmetic formulation market, because formulation teams can test more hypotheses when first-draft generation and screening take minutes instead of days. The practical benefit is not only time saved, it is the ability to explore a wider range of textures, actives, and combinations within the same budget and launch window. That matters most in color cosmetics, skin care, and trend-sensitive categories, where timing often determines whether a concept reaches shelf space before demand shifts.

South Korea provides a clear operating example, where Cosmax improved first-attempt color-matching success from 52% to 78.1%, reducing costly reformulation loops and improving floor-level efficiency in production-linked R&D. The same pattern appears in ingredient discovery, where LG Household & Health Care and LG AI Research used EXAONE Discovery AI to cut efficacy ingredient discovery timelines from 22 months to 1 day, showing how AI can expand competitive lead time rather than just automate routine tasks. As a result, the AI in cosmetic formulation market is benefiting from a direct link between faster cycles and stronger launch economics, which makes adoption easier to justify at the R&D leadership level.

High Implementation and Integration Cost

The AI in cosmetic formulation market still faces a real adoption barrier in the form of software, workflow, and organizational integration cost, especially for mid-tier brands and independent formulators. Buying a platform is only the first step, because most users also need cleaner data, compatible architecture, revised approval flows, and staff that can work confidently with AI-supported formulation outputs. Legacy PLM and ERP systems add another constraint, since many were not built to exchange data easily with newer formulation tools and therefore require custom integration work. This problem is most visible among smaller operators and emerging-market manufacturers, where capital budgets are tighter and payback periods above 2 years can delay decisions. Cloud-native delivery models help reduce upfront infrastructure burden, but they do not remove the need for change management and internal process redesign. As a result, the AI in cosmetic formulation market can advance quickly at the enterprise end while still developing unevenly across smaller customers that lack the resources to operationalize the same tools at scale.

Other drivers and restraints analyzed in the detailed report include:

• Clean and Safe Formulation Pressure
• Regulatory Workflow Automation
• Data Privacy and Formula IP Risk

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software accounted for 53.16% of revenue in 2025, which made it the largest component in the AI in cosmetic formulation market and reflected the central role of formulation lifecycle platforms, ingredient intelligence engines, and prediction tools. This leadership came from the ability of software to bring ingredient data, regulatory checks, and stability modeling into a single workflow, reducing the need for fragmented research and repeated manual reviews. In practice, these platforms serve as the operating layer through which formulators move from concept screening to draft formulas and compliance preparation. Nouryon’s April 2025 launch of BeautyCreations showed how ingredient suppliers are embedding AI into customer-facing discovery tools rather than treating it as a separate software category, which strengthens retention and deepens commercial relationships. Hardware and lab automation remained the smallest component, because physical execution tools still depend on AI-generated recommendations and matter most in high-volume, made-to-order settings where throughput discipline is critical. This pattern indicates that digital intelligence still captures more value than physical automation alone in the current stage of the AI in cosmetic formulation market.

Services are projected to grow at 24.88% CAGR through 2031, and that trajectory says as much about capability gaps as it does about software demand. The faster rise of services suggests that buyers have moved beyond awareness and licensing, but many still need outside help to integrate models, redesign workflows, and prepare internal teams for new decision processes. That is why consultants, systems integrators, and implementation partners are becoming a premium layer within the AI in cosmetic formulation industry, even as software platforms expand their feature sets. IBM’s January 2025 collaboration with L’Oréal is a strong example, because the project combined a custom generative AI foundation model with workflow redesign aimed at sustainable cosmetics creation, showing that value depends on both model quality and operating change. For mid-market users, the same logic makes third-party support the fastest path to adoption, since internal data science and systems integration teams are often limited. The gap between software share and services growth therefore shows that the AI in cosmetic formulation market is entering a maturity phase where deployment expertise remains scarce and commercially important.

Cloud deployment held 61.17% of revenue in 2025, giving it the lead in the AI in cosmetic formulation market because SaaS delivery lowers upfront cost, speeds updates, and makes regulatory database maintenance easier across multiple countries. This architecture fits brands and contract formulators that want continuous model improvement without managing internal infrastructure or rebuilding compliance rules by hand. It also supports mid-sized users that need faster adoption and lower total ownership cost, which helps explain why cloud became the dominant choice even before the market reached full scale. The regulatory case for cloud is especially strong in Europe, where frequent updates under Regulation (EC) No. 1223/2009 make manual internal refresh cycles expensive and slow. Cloud platforms also benefit from broader product velocity, since new assistants, interface changes, and screening features can be deployed across the user base without long local upgrade cycles. This has helped the AI in cosmetic formulation market build a practical adoption path for brands that want faster experimentation without large IT commitments.

Cloud is also the fastest-growing deployment mode, with 30.12% CAGR through 2031, which is notable because leading segments usually slow once they reach scale. That combination suggests continued migration from on-premises and hybrid setups rather than stable coexistence, especially among customers that value flexibility and lower implementation friction. It also points to a concentration effect where vendors that can combine strong models, current databases, and frequent product updates may widen their advantage over slower rivals. Even so, hybrid and private cloud options will remain relevant where formula confidentiality, audit control, or internal governance standards outweigh the benefits of shared architecture. These concerns are especially important for larger brands with proprietary formula libraries, since their historical data is one of the few assets capable of creating defensible performance gaps in the AI in cosmetic formulation industry. The long runway for cloud in the AI in cosmetic formulation market therefore comes from both mainstream SaaS expansion and newer adoption in APAC markets where penetration is still earlier.

Complete Report Scope:

• By Component
  • Software
  • Services
  • Hardware and lab automation tools
• By Deployment Mode
  • Cloud
  • On-premises
  • Hybrid and private cloud
• By Application
  • Product development
  • Ingredient analysis and discovery
  • Personalized formulation
  • Quality control and stability prediction
  • Regulatory compliance and safety assessment
• By End User
  • Cosmetic manufacturers
  • Personal care brands and brand owners
  • Contract manufacturers and private-label formulators
  • Ingredient suppliers
  • Research institutes and independent labs
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.18% of global revenue in 2025, which gave it the leading position in the AI in cosmetic formulation market because the region combines strong software capability, well-funded beauty innovators, and a regulatory setting that is becoming more data-intensive. The MoCRA framework has already increased the need for stronger safety substantiation and adverse event management, which makes AI-based screening and documentation more relevant in everyday formulation work. The FDA’s April 2026 deployment of an AI-powered Adverse Event Monitoring System further strengthens this direction, because it signals that oversight itself is becoming more automated and more dependent on data quality. North America also has a commercial advantage in personalized production models, where AI links consumer inputs to formula generation and manufacturing execution. That connection keeps the region important not only for software development, but also for proving that AI-led formulation can operate at real scale in customer-facing businesses.

Europe’s position is shaped by the strictest regulatory environment in the field, which creates both friction and specialized demand for explainable and traceable systems in the AI in cosmetic formulation market. The European Commission’s 2025-2026 evaluation of Regulation (EC) No. 1223/2009 is reviewing topics that include environmental chemical effects, digital labeling, and governance implications tied to AI use in cosmetic oversight. At the same time, the EU AI Act increases pressure on vendors to show model transparency and decision traceability when AI influences regulated outcomes. This favors vendors that can document how recommendations are generated and how formula decisions are reviewed by humans before launch. Germany, France, and the UK remain the core demand centers, supported by large regional ingredient suppliers whose R&D footprints help connect AI tools to real formulation workflows.

Asia-Pacific is the fastest-growing region, with 27.36% CAGR through 2031, which shows that the AI in cosmetic formulation market is expanding rapidly in ODM and OEM ecosystems where speed and flexibility directly affect competitiveness. South Korea is especially active, combining government-backed AI programs with manufacturing networks that can move from formulation concept to scaled production quickly. Japan adds depth through large beauty groups such as Shiseido and Kao, where internal AI platforms are being used for skin analysis, formulation recommendation, and sustainability screening. Kao’s upgraded Kirei Skin AI, which evaluates 77 skin parameters using 25 machine learning models and 70,389 training images, shows how regional players are turning AI into a differentiated science and product development asset. South America, the Middle East and Africa, and GCC markets remain earlier-stage adoption zones, but cloud delivery and supplier-led partnerships are making entry easier where local infrastructure is still developing.

List of Companies Covered in this Report:

• Albert Invent
• Amorepacific
• BASF
• Beiersdorf
• Evonik
• Geltor
• Givaudan
• Haut.AI
• IBM
• L'Oreal
• Nouryon
• Prose
• PROVEN Skincare
• Revieve
• Shiseido
• Symrise
• The Estee Lauder Companies
• Unilever

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support